EPTB diagnosis by GeneXpert MTB/RIF test and its Clinical-epidemiological profile

Simple item page
dc.contributor.authorDevi, A. Renukaen_US
dc.contributor.authorKumari, S. Shanthien_US
dc.contributor.authorSurekha, A.en_US
dc.date.accessioned2020-01-02T06:12:16Z
dc.date.available2020-01-02T06:12:16Z
dc.date.issued2019-01
dc.description.abstractGeneXpert is a novel, automated diagnostic test that can identify Mycobacterium tuberculosis (MTB) DNA and resistance to rifampicin (RIF) rapidly for Extrapulmonary tuberculosis (EPTB). Incidence of EPTB is increasing in low burden settings in comparison to pulmonary tuberculosis (PTB) & EPTB is relatively neglected. Aim: This study is aimed at knowing the incidence of EPTB and rifampicin sensitivity using an automated rapid detection method, GeneXpert. Methods: 271 EPTB positive patients were included in this retrospective study during a period from January to July 2018. Details regarding TB diagnosis, rifampicin sensitivity, nature of the sample and patient details including age, sex, occupation, address, habits, past history of TB, HIV status and other clinically relevant information was obtained from hospital and laboratory registers. Results: Out of 1290 tuberculosis positive patients, 1019 were of pulmonary tuberculosis (PTB) i.e., 78.9% and remaining 271 were of extrapulmonary tuberculosis (EPTB) i.e., 21.1%. 42.4% (115 out of 271) patients were in the age group of 31-40 years. Female predominance was observed in EPTB patients. Among 271 EPTB patients, 122 (45%) were diagnosed as pleural TB, 95 (35%) patients affected by tuberculosis at lymphnodes, 3(1.1%) had meningeal TB, 9(3.3%) EPTB cases were diagnosed from pus samples of various clinical conditions and remaining 42(15.4%) EPTB cases identified from various samples including tissues, genitourinary, synovial fluid, bones & joints. 247 (91.1%) out of 271 EPTB patients clinical samples showed rifampicin sensitive. 12 (9.8%) out of 122 pleural tuberculosis cases and 5 (5.2%) out of 95 TB lymphadenitis cases showed resistant rifampicin. Conclusion: TB can be diagnosed by various methods, among which GeneXpert is a rapid, reliable, easy to operate, automated system. GeneXpert helps physicians by providing rapid diagnosis within 90 minutes, in turn aid to initiate prompt treatment at the earliest.en_US
dc.identifier.affiliationsProfessor, Department of Microbiology, Kurnool Medical College, Kurnool, Andhra Pradesh.en_US
dc.identifier.affiliationsAssistant Professor, Department of Microbiology, Kurnool Medical College, Kurnool, Andhra Pradesh.en_US
dc.identifier.affiliationsProfessor & HOD, Department of Microbiology, Kurnool Medical College, Kurnool, Andhra Pradesh.en_US
dc.identifier.citationDevi A. Renuka, Kumari S. Shanthi, Surekha A.. EPTB diagnosis by GeneXpert MTB/RIF test and its Clinical-epidemiological profile. Annals of International medical and Dental Research. 2019 Jan; 5(1): 1-5en_US
dc.identifier.issn2395-2822
dc.identifier.issn2395-2814
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/189323
dc.languageenen_US
dc.publisherSociety for Health Care & Research Developmenten_US
dc.relation.issuenumber1en_US
dc.relation.volume5en_US
dc.source.urihttps://doi.org/10.21276/aimdr.2019.5.1.MB1en_US
dc.subjectExtrapulmonary Tuberculosisen_US
dc.subjectGeneXperten_US
dc.subjectRifampicinen_US
dc.titleEPTB diagnosis by GeneXpert MTB/RIF test and its Clinical-epidemiological profileen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
aimdr2019v5n1p1i.pdf
Size:
195.14 KB
Format:
Adobe Portable Document Format
Download
Collections
Annals of International Medical and Dental Research